AMRZ.SW is trading at $41.34, down 5.4%, as investors lock in gains following a strong rally since late June and a recent price-target reduction by Morgan Stanley.
- The stock is facing pressure from a softer broader market backdrop despite Amrize recently reaffirming its latest financial guidance.
- Sentiment remains mixed as the market weighs the recent analyst downgrade against sector research that previously identified the company as a top emerging stock.
- Shares had closed at $43.71 on July 7, 2026, before the current pullback prompted by profit-taking.